Rabeprazole
- Generic Name
- Rabeprazole
- Brand Names
- Aciphex, Pariet
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21N3O3S
- CAS Number
- 117976-89-3
- Unique Ingredient Identifier
- 32828355LL
- Background
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion.
- Indication
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevention of gastroinetestinal bleeds with NSAID use.
- Associated Conditions
- Duodenal Ulcer, Gastric Ulcer, Gastro-esophageal Reflux Disease (GERD), Heartburn, Helicobacter Pylori Infection, Non-erosive Reflux Esophagitis Disease (NERD), Vomiting, Zollinger-Ellison Syndrome, Develop NSAID-induced gastric ulcers, Erosive reflux esophagitis
Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets
- Conditions
- Gastroesophageal Reflux Disease
- Interventions
- Drug: Rabelis DDR 50 mg Capsules
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2018-12-12
- Lead Sponsor
- Neutec Ar-Ge San ve Tic A.Ş
- Target Recruit Count
- 48
- Registration Number
- NCT03037606
- Locations
- 🇹🇷
Ege University Facult of Medicine Gastroenterology Department, Izmir, Turkey
Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole
- Conditions
- Refractory Reflux Esophagitis
- Interventions
- First Posted Date
- 2016-12-08
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Xijing Hospital of Digestive Diseases
- Registration Number
- NCT02986685
- Locations
- 🇨🇳
Xijing Hosipital of Digestive Disease, Xi'an, Shaanxi, China
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients
- Conditions
- Duodenal Ulcer
- Interventions
- First Posted Date
- 2016-07-28
- Last Posted Date
- 2016-07-28
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 408
- Registration Number
- NCT02847455
Effect of Proton Pump Inhibitors on Palpitations
- Conditions
- Signs and Symptoms
- Interventions
- Drug: Pacebo
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Jordan Collaborating Cardiology Group
- Target Recruit Count
- 30
- Registration Number
- NCT02826408
- Locations
- 🇯🇴
Istishari Hospital, Amman, Jordan
Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2016-03-04
- Last Posted Date
- 2020-03-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT02699710
- Locations
- 🇬🇧
Quotient Clinical Ltd, Clinical Research Unit, Nottingham, United Kingdom
A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- First Posted Date
- 2016-01-14
- Last Posted Date
- 2020-08-06
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT02655614
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
🇺🇸Mayo Clinic Hospital - Florida, Jacksonville, Florida, United States
🇺🇸Forbes Norris Mda/als Ctr; Research Center, San Francisco, California, United States
Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.
- First Posted Date
- 2015-12-23
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Il-Yang Pharm. Co., Ltd.
- Target Recruit Count
- 176
- Registration Number
- NCT02638584
- Locations
- 🇰🇷
HALLYM UNIVERSITY MEDICAL CENTER, Chuncheon Sacred Heart Hospital, Chuncheon, Gangwon-do, Korea, Republic of
Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions
- Conditions
- Gastrointestinal Diseases
- Interventions
- Drug: IDIAZOLE 20mg DR tabs
- First Posted Date
- 2015-11-16
- Last Posted Date
- 2018-10-01
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 70
- Registration Number
- NCT02605395
- Locations
- 🇪🇬
GSK Investigational Site, Cairo, Egypt
PPI And Food Effect Study For PF-06463922 In Healthy Volunteers
- First Posted Date
- 2015-10-06
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 27
- Registration Number
- NCT02569554
- Locations
- 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium
Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
- Conditions
- Gastroesophageal Reflux Disease (GERD)Community-acquired Pneumonia
- Interventions
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2015-09-22
- Lead Sponsor
- Canadian Network for Observational Drug Effect Studies, CNODES
- Target Recruit Count
- 4238504
- Registration Number
- NCT02555852
- Locations
- 🇨🇦
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.